CHUANGLIAN HOLD_Providing professional financial news and data related to CHUANGLIAN HOLD, committed to creating a comprehensive and efficient information access channel for users | NewTimeSpace

CHUANGLIAN HOLD (02371.HK): Zhang Jie Resigns as Executive Director, Gao Rui Appointed to Replace Him, Effective 12 August 2026

Tags：

CHUANGLIAN HOLD 02371.HK Board Change

2026-08-12

CHUANGLIAN HOLD(02371.HK): Wholly-owned Subsidiary Signs MOU with Payment Tech Firm to Explore Digital Asset Payment and RWA Solutions

Tags：

CHUANGLIAN HOLD 02371.HK memorandum of understanding

2026-06-26

Finance
China Aluminum Cans (06898.HK): H1 Net Profit Expected to Rise Over 30% Year-on-Year
Finance
CSPC Pharmaceutical Group (01093.HK): Receives US$30 Million Upfront Payment Under siRNA Collaboration Agreement with AstraZeneca
Finance
New City Development Group (00456.HK): Appointment of Li Yang as Co-Chief Executive Officer
Finance
ORIENTAL EXPL (00430.HK): Expects Interim Profit to Fall to Approximately HK$ 3,000,000-3,200,000 on Lower Rental Income
Finance
V.S. INT'L (01002.HK): Expects Interim Profit of USD 3,000,000-4,000,000, Markedly Up from the Same Period Last Year
Finance
HENGRUI PHARMA (01276.HK): SHR-7590 Injection Receives Drug Clinical Trial Approval Notice for Ulcerative Colitis and Crohn's Disease
Finance
CAPINFO (01075.HK): Expects Interim Results to Swing to Loss of Approximately RMB 30-50 Million
Finance
CH TIANBAO GP (01427.HK): Expects Interim Net Loss to Widen to RMB 60-70 Million on Reduced Revenue
Finance
MULTIFIELD INTL (00898.HK): Expects Interim Profit to Fall to Approximately HK$ 100-120 Million on Lower Fair Value Gains on Financial Assets
Finance
HENGRUI PHARMA (01276.HK): HRS-4729 Injection Approved for Phase II Clinical Trial in Type 2 Diabetes

Scan QR Code

Download App